Evidence map›Paper›PMID 26895107›Full record

ArticleOncotarget2016

The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.

Mitsuru Okuno, Ichiro Yasuda, Seiji Adachi, Masanori Nakashima, Junji Kawaguchi, Shinpei Doi, Takuji Iwashita, Yoshinobu Hirose, Osamu Kozawa, Naoki Yoshimi and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mitsuru OkunoDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Ichiro YasudaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Seiji AdachiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Masanori NakashimaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Junji KawaguchiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Shinpei DoiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Takuji IwashitaDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Yoshinobu HiroseDepartment of Pathology, Osaka Medical College, Takatsuki, Osaka, 569-8686, Japan.
Osamu KozawaDepartment of Pharmacology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Naoki YoshimiDepartment of Pathology and Oncology, Graduate School of Medical Science, University of the Ryukyus, Nishihara-cho, Okinawa, 903-0215, Japan.
Masahito ShimizuDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Hisataka MoriwakiDepartment of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Gifu University · JPOsaka Medical and Pharmaceutical University · JPUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe precise role of phosphorylated heat shock protein (HSP) 27 (p-HSP27) in pancreatic cancer remains to be elucidated. The aim of this study was to investigate whether the expression of p-HSP27 predicts the prognosis of patients with pancreatic cancer.

methodsWe retrospectively assessed 49 biopsied pancreatic cancer tissue samples that were obtained prior to the treatment with gemcitabine. The correlations between p-HSP27 and the clinicopathological characteristics were analyzed.

resultsp-HSP27 was not correlated with the response to chemotherapy or histological type. However, the median survival time was significantly longer in the patients with high p-HSP27 (275 days, n = 18) than those with low p-HSP27 (205 days, n = 31) (P = 0.0158). A multivariate Cox proportional hazards regression analysis revealed that low p-HSP27 predicted a worse prognosis.

conclusionsHigher p-HSP27 expression before chemotherapy was correlated with better survival, indicating that p-HSP27 expression could be used to predict the prognosis of pancreatic cancer.

Indexed as

AdultAgedAged, 80 and overAntimetabolites, AntineoplasticBiomarkers, TumorDeoxycytidineFemaleFollow-Up StudiesGemcitabineHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansMaleMiddle AgedMolecular ChaperonesNeoplasm InvasivenessAntimetabolites, AntineoplasticBiomarkers, TumorDeoxycytidineGemcitabineHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanMolecular ChaperonesHSP27pancreatic cancerphosphorylationprognosis

Identifiers

PMID26895107
PMCPMC4924715
OpenAlexW2311020746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.